Рентгеноэндоваскулярная хирургия в лечении больных ИБС с морфологически неблагоприятными диффузными формами распространенного поражения венечного русла
![Диссертация: Рентгеноэндоваскулярная хирургия в лечении больных ИБС с морфологически неблагоприятными диффузными формами распространенного поражения венечного русла](https://westud.ru/work/2519443/cover.png)
С внедрением и совершенствованием методики селективной коронарографии Ф. Соунсом и М. Джадкинсом в конце 60-х годов прошлого столетия встал вопрос о возможности транскатетерного устранения обструктивных поражений коронарного русла. Впервые транслюминальная баллонная ангиопластика сужения нативной коронарной артерии была выполнена А. Грюнтцигом 16 сентября 1977 г., после чего развитие… Читать ещё >
Содержание
- Список сокращений
- Цель и задачи исследования
- Глава 1.
- Обзор литературы
- 1. 1. Эпидемиология и патофизиология ИБС
- 1. 2. Основные механизмы рентгеноэндоваскулярного лечения
- 1. 3. Определение морфологически неблагоприятных вариантов поражения 16 коронарного русла, а также других факторов риска, влияющих на выполнение эндоваскулярных вмешательств
- 1. 4. Исторические аспекты и современные подходы к jg рентгеноэндоваскулярному лечению больных с диффузным многососудистым поражением коронарного русла
- 1. 5. Результаты рентгеноэндоваскулярного лечения хронических тотальных ^ окклюзий коронарных артерий
- Клинический материал, методы исследования и лечения
- 2. 1. Критерии включения в исследование
- 2. 2. Электрокардиографическое и эхокардиографическое исследование
- 2. 3. Методика проведения велоэргометрического исследования
- 2. 4. Методика проведения стресс — эхокардиографического исследования
- 2. 5. Методика выполнения селективной коронарографии и левой 69 вентрикулографии, анализ данных коронарографии
- 2. 6. Методика выполнения коронарной ангиопластики, критерии оценки 74 результатов рентгеноэндоваскулярных вмешательств
- 2. 7. Статистический анализ
- Глава 3. 83~
Результаты рентгеноэндоваскулярного лечения пациентов с имплантированными непокрытыми стентами. 3.1. Исходная клиническая характеристика пациентов первой группы. 3.2. Непосредственные результаты рентгеноэндоваскулярных вмешательств у пациентов первой группы. 3.3. Анализ отдаленных результатов рентгеноэндоваскулярных вмешательств у пациентов первой группы. 3.4. Примеры клинических наблюдений.
Гпава 4. Результаты рентгеноэндоваскулярного лечения пациентов с имплантированными стентами с антипролиферативным покрытием. 4.1. Исходная клиническая характеристика пациентов второй группы. 4.2. Непосредственные результаты рентгеноэндоваскулярных вмешательств у пациентов второй группы. 4.3. Отдаленные результаты рентгеноэндоваскулярных вмешательств у пациентов второй группы. 4.4. Примеры клинических наблюдений.
Глава 5. Обсуждение.
Список литературы
- Абугов С.А. Баллонная коронарная ангиопластика у больных ишемической болезнью сердца с неблагоприятными морфологическими и клиническими особенностями. Автореферат дисс. д.м.н. Москва, 1998 г.
- Беленков Ю.Н., Акчурин Р. С., Савченко А. П. с соавт. Результаты коронарного стентирования и хирургического лечения у больных ИБС при многососудистом поражении коронарного русла. Бюллетень НЦССХ им. А. Н. Бакулева РАМН 2002- томЗ, № 6. С. 35.
- Бабунашвили A.M., Иванов В. А., Дундуа Д. П., Кавтеладзе З. А., Карташов Д. С., Новичкова Е. Н., Юдин И. Е. Метод комплексной эндоваскулярной коррекции в лечении больных с распространенным атеросклерозом коронарных артерий. 2003, № 2. С. 46−50.
- Бокерия Л.А., Апекян Б. Г. Рентгеноэндоваскулярная хирургия заболеваний сердца и сосудов в Российской Федерации 2006 г. Москва, Издательство НЦССХ им. А. Н. Бакулева РАМН, 2007 г.
- Бокерия Л.А., Гудкова Р. Г. Сердечно-сосудистая хирургия 2006. Болезни и врожденные аномалии системы кровообращения. М., НЦССХ им. А. Н. Бакулева РАМН, 2007 г. С. 3−30.
- Здоровье населения и деятельность учреждений здравоохранения в 2001 г. Справочник Министерства Здравоохранения РФ. Москва, 2002 г.
- Иванов В.А., Трунин И. В., Бобков Ю. А. с соавт. Ангиопластика при множественных поражениях коронарных артерий, 6 летний опыт. Бюллетень НЦССХ им. А. Н. Бакулева РАМН 2002- томЗ, № 6. С. 39.
- Колесов ВИ. Хирургия венечных артерий сердца. Ленинград. Медицина. 1977 г. 344 с. 9
- Ю.Меркулов Е. В., Самко А. Н., Ширяев А. А. с соавт. Многососудистая ангиопластика и коронарное шунтирование: сравнение непосредственных и отдаленных результатов. Бюллетень НЦССХ им. А. Н. Бакулева РАМН 2004- том 5, № 11. С. 204.
- Руденко Б.А. Первичная и вторичная эндоваскулярная реваскуляризация миокарда с использованием баллоннной ангиопластики и коронарного стентирования у больных ишемической болезнью сердца. Автореферат дисс. д.м.н. Москва, 2004 г.
- Саакян Ю.М. Баллонная коронарная ангиопластика у больных ишемической болезнью сердца при многососудистом поражении коронарного русла. Автореферат дисс. к.м.н. Москва, 1997 г.
- Чазов Е.И., ред. Болезни сердца и сосудов в 4 томах. Москва, Медицина, 1992 г. Том 2: 5−136.
- Чазов Е.И., ред. Болезни сердца и сосудов в 4 томах. Москва, Медицина, 1992 г. Том 2: 136−177.
- Abrams J. Stable angina. N Engl J. Med 2005- 352: 2524−2533.
- Alderman EL, Bourassa MG, Cohen LS et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990- 82: 1629−1646.
- Bell MR, Gersh BJ, Schaff HV et al. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the CASS registry. Circulation 1992- 86:446−457.
- Bergsma TM, Grandjean JG, Voors AA et al. Low reccurence of angina pectoris after coronary artery bypass graft surgery with bilateral internal thoracic and right gastroepiploic arteries. Circulation 1998- 97: 2402−2405.
- Beyar R, Roguin A. The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured? Eur Heart J 2001- 22: 2054−2057.
- Bittl JA. Advances in Coronary Angioplasty. New Engl J Med- 1996: 335:1290−1302.
- Bittl JA, Chew DP, Topol EJ et al. Meta-Analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty. J Am Coll Cardiol 2004- 43, 6: 936−942.
- Block PC, Myler RK, Stertzer S et al. Morphology after transluminal angioplasty in human beings. N Engl J Med 1981- 305: 382−385.
- Block P, Petch MC, Letouzey JP Manpower in cardiology in Europe. Eur Heart J2000- 21 (14): 1135−1140.
- Bourassa MG. Clinical trials of coronary revascularization: coronary angioplasty versus coronary bypass grafting. Curr Opin Cardiol 2000- 15: 281−286.
- Braunwald E, Jones RH, Mark DB et al. Diagnosing and managing unstable angina. Agency for health care policy and research. Circulation 1994, 90: 613−622.
- Brenner DJ, Miller RC. Long-term efficasy of intracoronary irradiation in inhibiting in-stent restenosis. Circulation 2001- 103: 1330−1332.
- Burke SE, Lubbers NL, Chen YW et al. Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin. J Cardiovasc Pharmacol 1999- 33: 829−835.
- CABRI Trial Participants. First year results of CABRI (The Coronary Angioplasty versus Bypass Revasculariztion Investigation). Lancet 1995- 346: 1179−84.
- Caracciolo EA, Davis KB, Sopko G et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease: long term CASS experience. Circulation 1995- 91: 2335−2344.
- Chaitman BR, Fisher LD, Bourassa MG et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease: report of the Collaborative Study in CASS. Am J Cardiol 1981- 148: 765−777.
- Colombo A. 12-Month clinical follow-up of the TAXUS II paclitaxel-eluting stent study. ACC 2003- http://www.medscape.com/viewarticle/451 913
- Colombo A. Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting. Catheter Cardiovasc Interv 2004- 63: P. 61−62.
- Coronary artery surgery study (CASS): a randomized trial of coronary artery bypasssurgery: quality of life in patients randomly assigned to treatment groups. Circulation 1983- 68: 951−960.
- Cultip DE, Chhabra AG, Baim DS et al. Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials. Circulation 2004 110: 1226−1230.
- Drachman DE, Edelman ER, Seifert P, et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol 2000- 36:2325−32.
- Eagle K, Guyton R, Davidoff R et al. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery. JACC- 2004: Vol. 44, No. 5. P. e213-e310.
- Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina: the Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med 1984- 311: 1333−1339.
- Elezi S, Dibra A, Schomig A, Kastrati A. Current drug-eluting stents in complex patients and lesions. Minerva Cardioangiol. 2006 Feb-54(1):5−22.
- Ellis SG, Cowley MJ, DiSciascio G et al. Determinants of 2-year outcome after coronary angioplasty in patients with multivessel disease on the basis of comprehensive preprocedural evaluation. Circulation 1991- 83:1905−14.
- Ellis SG, Savage M, Fischman D et al. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries: initial results of a multicenter experience. Circulation 1992- 86: 1836−1844.
- Ellis SG, Vandormael MG, Cowley MJ, and the POSCH Group. Coronary morphologic and clinical determinates of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 1990−82:1193−1202.
- European Coronary Surgery Study Group. Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982- 2: 1173−1180.
- Farb A, Heller P, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001- 104:473−479.
- Farkouh ME, Dangas G, Leon MB et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008 Feb-155(2):215−23.
- Faxon DP, Kelsey SF, Ryan TJ, McCabe CH, Detre K. Determinants of successful percutaneous transluminal coronary angioplasty: report for the National Heart, Lung, and Blood Institute Registry. Am Heart J 1984- 108:1019−1023.
- Fischman DL, Leon MB, Baim DS et al, for the Stent Restenosis Study investigators. A randomised comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994- 331: 496−501.
- Galafiore AM, Di Giammarco G, Teodori G et al. Midterm results after minimally invasive coronary surgery. J Thorac Cardiovasc Surg 1998- 115: 763−771.
- Gallo R, Padurean A, Jayaraman T et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999- 99: 2164−2170.
- Garrett HE, Dennis EW, DeBakey ME. Aortocoronary bypass with saphenous viengraft: seven-year follow-up. J Am Medical Association 1973- 223: 792−794.
- Garcia E, Serruys PW, Dawkins К et al. BENESTENT-ll Trial final results of visit II & III: a 7 month follow-up abstract. Eur Heart J 1997- 18 (suppl): 350.
- Geissler HJ, Holzl P, Marohl S et al. Risk stratification in heart surgery: comparison of six score systems. Eur J Cardiothorac Surg 2000−17(4): 400−6.
- Gersh BJ et al: Chronic coronary artery disease, in Heart Disease, 5th ed, E Braunwald (ed). Philadelphia, Saunders, 1997- 1289−1365.
- Gertz SD, Roberts WC. Haemodynamic sheer force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol 1990- 66: 1368−1372.
- Gibbons RJ et al. ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina. A Report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol 1999- Vol 33, No. 7- 2092−2197.
- Gowda RM, Khan LA, Vasavada ВС et al. Efficacy and safety of endovascular intracoronary brachytherapy. J Am Coll Cardiol 2004- 93, 1: 1−5.
- Grenadier E, Roguin A, Hertz I, et al. Stenting very small coronary narrowings (< 2 mm) using the biocompatible phosphoryl-choline-coated coronary stent. Catheter Cardiovasc Interv 2002- 55:303−8.
- Grube E, Silber S, Hauptmann K, et al. TAXUS I: six- and twelvemonth results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003- 107:38−42.
- Gruentzig AR, Myler RK, Hanna ES et al. Coronary transluminal angioplasty. Circulation 1977- III-84 (suppl III): 55−56.
- Gruentzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1978−1: 263.
- Gruentzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979- 301:61−68.
- Gruentzig AR, King SB III, Schlumpf M et al. Long-term follow-up after percutaneous transluminal coronary angioplasty: the early expirience. N Engl J Med 1987- 316: 1127−1132.
- Hangartner JR, Charleston AJ, Davies MJ et al. Morphological characteristics ofclinically significant coronary artery stenosis in stable angina. Br Heart J 1986- 56: 501−508.
- Hannan EL, Racz MJ, Walford G et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005- 352: 2174−2183.
- Haudenschild CC. Pathobiology of restenosis after angioplasty. Am J Med 1993- 94: 40S-44S.
- Heldman A, Cheng L, Jenkins G, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001- 103:2289−2295.
- Hoffmann R, Mintz GS. Coronary instent restenosis predictors, treatment and prevention. Eur Heart J 2000- 21:1739−1749.
- Henderson RA, Pocock SJ, Clayton TC et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003- 42: 1161−1170.
- Holmes D, Fitzgerald P, Goldberg S et al. The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial. Am Heart J 2000- 139: 23−31.
- Judkins MP. Selective coronary arteriography: A percutaneous transfemoral technique. Radiology 1967. 89: 815−824.
- Kern M, ed. Basic coronary balloon angioplasty and stenting. In: The Interventional Cardiac Catheterization Handbook, second edition. Elsevier Inc, 2004. P. 11−72.
- Khan NE, De Souza A, Mister R et al. A randomized comparison of off-pump and on-pump multivessel coronary artery bypass surgery. New Engl J Med, 2004- 350.1. P. 21−28.
- Kim YH, Park SW, Lee SW et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation. 2006 Nov 14- 114(20):2148−53. Epub 2006 Oct 23
- Kim HS, Waksman R, Cottin Y et al. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. J Am Coll Cardiol 2001- 37: 1026−1030.
- Kleiman NS, Rodriguez AR, Raizner AE. Interobserver variability in grading of coronary arterial narrowings using the American College of Cardiology/ American Heart Association grading criteria. Am J Cardiol 1992- 69: 413−415.
- Kloster FE, Kremkau EL, Ritzman LW et al. Coronary bypass for stable angina: a prospective randomized study. N Engl J Med 1979- 300: 149−157.
- Kolessov VI. Mammary artery coronary artery anastomosis as a method of treatment for angina pectoris. J Thorac Cardiovasc Surg 1967- 54: 535−544.
- Kornowski R, Mehran R, Satler LF et al. Procedural results and late clinical outcomes following multivessel coronary stenting. J Am Coll Cardiol 1999- 33: 420 426.
- Kumbhani DR. The Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX — Presented at ESC 2008).
- Lallemant R, Bauters C, Leroy F et al. L’angioplastie coronaire des lesions multitronculaires. A propos de 1664 procedures. Arch Mai Coeur 1992- 85: 815−22.
- Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M- Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and' compromised left ventricular function. Circulation. 1981−63(2):285−99.
- Lee CW, Park KH, Kim YH et al. Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions. Am J Cardiol. 2006 Oct 1−98(7):918−22.
- Le Feuvre C, Bonan R, Cote G et al. Five- to ten-year outcome after multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol 1993- 71 (13): 11 531 158.
- Le Feuvre C, Bonan R, Lesperance J et al. Predictive factors of restenosis after multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol. 1994- 73 (12): 840−844.
- Lefevre T, Louvard Y, Morice MC, et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv. 2000−49:274−83.
- Lefkovits J, Topol EJ. Pharmacological approaches for the prevention of. restenosis after percutaneous coronary intervention. Prog Cardiovasc Dis- 1997- 40:141−58.
- Legrand V, Serruys PW, Emanuelsson H. et al. BENESTENT-II Trial final results of visit I: a 15-day follow-up abstract. J Am Coll Cardiol 1997- 29 (suppl A): 170A.
- Legrand VM, Serruys PW, Unger F et al. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 2004- 109: 1114−1120.
- Macaya C, Serruys PW, Ruygrok P et al. Continued benefit of coronary stenting versus balloon angioplasty: one year clinical follow-up of Benestent trial. J Am Coll Cardiol 1996- 27: 255−261.
- Mather VS, Guinn GA. Prospective randomized study of the surgical therapy of stable angina. Cardiovasc Clin 1977- 8:131−144.
- Mathew V, Garratt KN, Holmes DR Jr. Clinical outcome after multivessel coronary stent implantation. Am Heart J 1999- 138: 1105−1110.
- Malik N, Gunn J, Shepherd L, et al. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility. J Invasive Cardiol 2001- 13:193−201.
- Mann JM, Davies MJ. Epidemiology and pathophysiology of coronary arterydisease. Practical interventional cardiology. Ed Grech ED, Ramsdale DR. Mosby 1997: 1−9.
- Мак KH, Topol EJ. Clinical trials to prevent restenosis after percutaneous coronary revascularization. Ann N Y Acad Sci 1997- 811:255−84- discussion 284−8.
- Marx SO, Jayaraman T, Go LO, et al. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995- 76:412−7.
- Mintz GS, Popma J J, Pichard AD et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996- 94: 35−43.
- Michels M, Caliskan K, Ong ATL et al. Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery. Eurointerv 2005- 1: 181−185.
- Morice M, Serruys P, Sousa J, et al. The RAVEL study: a randomized study with the sirolimus coated Bx-velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. Eur Heart J 2001: (Abstract).
- Morice M, Serruys P, Sousa J, et al. A randomized comparison of a sirolimus eluting stent with a standart stent for coronary revascularization. N Engl J Med 2002- 346:1773−1780.
- Moses J, O’Schaughnessy C, Caputo R, et al. The U.S. multicenter, randomized, double-blind study of the sirolimus-eluting stent in coronary lesions. Eur Heart J 2002- 23:264.
- Moushmoush B, Kramer B, Hsieh AM, Klein LW. Does the AHA/ACC task force grading system predict outcome in multivessel coronary angioplasty? Cathet
- Cardiovasc Diagn 1992- 27: 97−105.
- Moussa I, Reimers B, Moses J et al. Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting. Circulation 1997- 96: 3873−3879.
- Mueller RL, Rosengart TK, Isom OW. The history of surgery for ischemic heart disease. Ann Thorac Surgery 1997- 63: 869−878.
- Muller DW, Topol EJ, Abrams GD, et al. Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. J Am Coll Cardiol 1992- 20:460−6.
- Murphy JG. A monk’s prayer: О Lord what is the answer to in-stent restenosis? Commentary on the TRAPIST Study. Eut Heart J 2001- 22: 1847−1849.
- Myers WO, Gersh BJ, Fisher LD et al. Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg 1987- 44: 471−486.
- Myler RK, Shaw C, Stertzer SH, Hecht HS, Ryan C, Rosenblum J, Cum-berland DC, Murphy MC, Hansell HN, Hidalgo B. Lesion morphology and coronary angioplasty: current experience and analysis. J Am Coll Cardiol 1992- 19:16 411 652.
- Nashef SAM, Roques F, Michel P et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999−16(1):9−13.
- Nashef SAM, Michel P et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19 030 patients. European Journal of Cardio-thoracic Surgery 15 (1999), 816−823.
- Nashef SA, Roques F, Hammill BG et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. European Journal of Cardio-thoracic Surgery 22 (2002) 101−105.
- Nobuyoshi M, Kimura T, Nosaka H et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988- 12: 616−623.
- Norris RM, Agnew TM, Brandt PWT et al. Coronary surgery after reccurentmyocardial infarction: progress of a trial comparing surgical and nonsurgical management for asymptomatic patients with advanced coronary disease. Circulation 1981- 63: 785−792.
- O’Keefe JH, Rutherford BD, McConahay DR et al. Multivessel coronary angioplasty frov 1980 to 1989: procedural results and long-term outcome. J Am Coll Cardiol 1990- 16:1097−102.
- O’Keefe JH, McCallister BD, Bateman TM, et al. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 1992- 19:1597−600.
- Ong AT, Serruys PW, Mohr FW et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J. 2006 Jun- 151 (6): 1194−204.
- Orlic D, Bonizzoni E, Stankovic G et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. J Am Coll Cardiol 2004- Vol. 43, No. 7. P. 1154−1160.
- Patil CV, Nikolsky E, Boulos E et al. Multivessel coronary artery disease: current revascularization strategies. Eur Heart J 2001- 22: 1183−1197.
- Pocock SJ, Henderson RA, Clayton T et al. Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. J Am Coll Cardiol 2000- 35: 907−914.
- Puel J, Joffre F, Rousseau H, Guermonprez B, Lancelin B, Morice MC. Endoprotheses coronariennes auto-expansives dans le prevention des restenoses apres angioplastie transluminal. Arch Mai Coeur 1987- 8: 1311−12.
- Roberts WC, Kragel AH, Gertz D et al. The heart in fatal unstable angina pectoris. Am J Cardiol 1991- 68: 22B-27B.
- Rodriguez et al. НАЗВАНИЕ J Am Coll Cardiol 2001- 37: 51−58.
- Rogers WJ, Coggin CJ, Gersh BJ et al. Ten-year follow-up of quality of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery: the Coronary Artery Surgery Study (CASS). Circulation 1990- 82: 16 471 658.
- Rosanio S, Tocchi M, Patterson C, et al. Prevention of restenosis after percutaneous coronary interventions: the medical approach. Thromb Haemost 1999- 82 Suppl 1:164−70.
- Roubin GS, Cannon AD, Agrawal SK et al. Intracoronary stenting for acute andthreatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992- 85: 916−927.
- Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engi J Med 1995- 332:100 414.
- Roy P, Torguson R, Okabe T et al. Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheter Cardiovasc Interv. 2007 Aug 1−70(2): 167−72.
- Ruygrok P. In SPIRIT II, XIENCE V demonstrated superiority versus TAXUS with a statistically significant 69% reduction in the primary endpoint of in-stent late loss at 6 months. Eurolntervention J. 2007−3:315−320.
- Ryden L, Simoons ML. The European Society of Cardiology into the next decade. Eur Heart J 2000−21 (15): 1193−1201.
- Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979- 277:665−7.
- Sculpher M, Smith D, Clayton T et al. Coronary angioplasty versus medicaltherapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial. Eur Heart J 2002- 23 (16): 12 371 239.
- Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22, 989) a new antifungal antibiotic. Fermentation, isolation and characterization. J Antibiot (Tokyo) 1975- 28: 727−735.
- Serruys PW, Lujiten H, Beatt К et al. Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. Circulation, 1988- 77: 361−377.
- Serruys PW, de Jaegere P, Kiemeneij F et al, for the Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty inpatients with coronary artery disease. N Engl J Med 1994- 331: 489−495.
- Serruys PW, Unger F, Sousa EJ et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001- 344:1117−1124.
- Serruys PW. ARTS I the rapamycin eluting stent- ARTS II — the rosy prophecy. Eur Heart J 2002−23:757−9.
- Serruys PW, Ong ATL, Morice MC et al. Arterial Revascularisation Therapies Study Part II sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. Eurolnterv 2005- 2: 147−156.
- Shaw RE, Anwar A, Myler RK et al. Incomplete revascularization and complex lesion morphology: relationship to early and late results in multivessel coronary angioplasty. J Inv Cardiol 1990- 2: 93−101.
- Sheiban I, Ballari GP, Moretti С et al. Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results. J Cardiovasc Med (Hagerstown). 2007 Aug-8(8):582−8.
- Shumacker HB. The evolution of cardiac surgery. Bloomington, IN: Indiana University Press, 1992.
- Sianos G, Morel MA, Kappetein AP et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Eurolnterv.2005−1:219−227.
- Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987- 316: 701−706.
- Silber S, Albertsson P, Aviles F et al. Guidelines for percutaneous coronary interventions. European Heart Journal, 2005- 26: 804−847.
- Smith SC, Dove JT, Jakobs AK et al. ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines). J Am Coll Cardiol 2001- 37: 2239i 2239lxvi.
- Smith SC, Feldman ТЕ, Hirsgfeld JW et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. JACC, 2006- 47: 1−121.
- Sones FM Jr, Shirey EK. Cine coronary arteriography. Circulation 1959- 20: 773.
- Spodick DH. Cardiology 1999. Ann Intern Med 2000- 133 (3): 244.
- Stone G et al. In SPIRIT III, XIENCE V demonstrated superiority versus TAXUS with a statistically significant 50% reduction in the primary endpoint of in-segment late loss at 8 months. JAMA. 2008−299(1b): 1903−1913.
- Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. New Engl J Med 2004- 350: 221−231.
- Stone GW, Ellis SG, Cannon L, et al. Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease: A Randomized Controlled Trial. JAMA 2005- 294: 1215−1223.
- Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001- 104:1188−1193.
- Tan K, Sulke N, Taub N, Sowton E. Clinical and lesion morphological determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol 1995−25:855- 865.
- Tanabe K, Serruys PW, Grube E, et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003- 107:559−64.
- The RITA-2 Trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomized Intervention Treatment of Angina (RITA-2) trial. Lancet 1997- 350: 461−468.
- The VA Coronary Artery Bypass Surgery Cooperative Study Group. Eighteen-year follow-up in the Veterans Affairs Cooperative Study of coronary artery bypasssurgery for stable angina. Circulation 1992- 86: 121−130.
- Topol’EJ. Textbook of interventional cardiology, 3rd ed. Philadelphia: WB Saunders Co.-1998. p 728.
- Van Beusekom HM, Serruys PW, Van der Giessen W. Coronary stent coatings. Coron Artery Dis 1994- 5:590−6.
- Van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996- 94:1690−7
- Van der Giessen WJ, Schwartz RS. Coated and active stents: an introduction. Semin Interv Cardiol 1998- 3:125−6.
- Van Hout B, van der Woude T, de Jaegere PT et al. Cost effectiveness of stent implantation versus PTCA: the BENESTENT experience. Semm Intervent Cardiol 1996−1:263−68.
- Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988- 319: 332−337.
- Virmani R, Burke AP, Kolodgie FD et al. Understanding atherosclerotic coronary artery disease: what makes the plaque unstable? Paris Course of Revascularization 2003- 7−30.
- Weintraub W, King S, Douglas J, Kosinski A. Percutaneous transluminal coronary angioplasty as a first revascularization procedure in single-, double- and triple-vessel coronary artery disease. J Am Coll Cardiol 1995- 26: 142−151.
- Whelan DM, Van der Giessen WJ, Krabbendam SC, et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000- 83:338−45.
- Whitlow PL, Dimas AP, Bashore TM et al. Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 1999- vol 34:1750−59.
- Wilson WS, Stone GW. Late results of percutaneous transluminal coronary angioplasty of two or more major native coronary arteries. Am J Cardiol 1994−73(15): 1041−1046.
- Yusuf S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994- 344: 563−570.